HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

OPA1 requires mitofusin 1 to promote mitochondrial fusion.

Abstract
The regulated equilibrium between mitochondrial fusion and fission is essential to maintain integrity of the organelle. Mechanisms of mitochondrial fusion are largely uncharacterized in mammalian cells. It is unclear whether OPA1, a dynamin-related protein of the inner membrane mutated in autosomal dominant optic atrophy, participates in fusion or fission. OPA1 promoted the formation of a branched network of elongated mitochondria, requiring the integrity of both its GTPase and C-terminal coiled-coil domain. Stable reduction of OPA1 levels by RNA interference resulted in small, fragmented, and scattered mitochondria. Levels of OPA1 did not affect mitochondrial docking, but they correlated with the extent of fusion as measured by polyethylene glycol mitochondrial fusion assays. A genetic analysis proved that OPA1 was unable to tubulate and fuse mitochondria lacking the outer membrane mitofusin 1 but not mitofusin 2. Our data show that OPA1 functionally requires mitofusin 1 to regulate mitochondrial fusion and reveal a specific functional difference between mitofusin 1 and 2.
AuthorsSara Cipolat, Olga Martins de Brito, Barbara Dal Zilio, Luca Scorrano
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 101 Issue 45 Pg. 15927-32 (Nov 09 2004) ISSN: 0027-8424 [Print] United States
PMID15509649 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • GTP Phosphohydrolases
  • Mfn1 protein, mouse
  • Mfn2 protein, mouse
  • Opa1 protein, mouse
Topics
  • Animals
  • Cells, Cultured
  • GTP Phosphohydrolases (antagonists & inhibitors, deficiency, genetics, physiology)
  • Gene Targeting
  • In Vitro Techniques
  • Membrane Fusion
  • Mice
  • Mice, Knockout
  • Mitochondria (physiology, ultrastructure)
  • RNA Interference

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: